The benefits Perspire’s infrared sauna and red light therapy provides are unmatched. There’s a demand for the science-backed treatment and I’m excited to bring it to the Paradise Valley & Scottsdale community.

SCOTTSDALE, Ariz. (PRWEB)
April 05, 2022

Perspire Sauna Studio, the original infrared sauna franchise to make natural health, wellness and beauty benefits available to individuals in an accessible and affordable delivery, is coming soon to Scottsdale and the Paradise Valley area. Slated to open this summer, this studio marks the second location to open in Arizona.

Located at 7001 N Scottsdale Rd at the intersection of Indian Bend & Scottsdale Roads, the 1,900-square-foot studio will hold 10 all private, top-of-the-line custom infrared saunas, each having the capability to hold either single or double person capacity. The Seville Shops & Dining center is home to a number of health and wellness-minded concepts including Orangetheory Fitness, Cyclebar, Massage Envy, and others. The location is perfectly situated to serve Scottsdale and Paradise Valley residents.

“I’ve been a wellness enthusiast my entire life but predominantly so in my later adult life. I am familiar with a lot of health and wellness concepts and corresponding benefits, but after being introduced to Perspire, I immediately knew I had to be a part of this movement,” said Maureen Rzeppa, franchisee and owner of Perspire Sauna Studio in Paradise Valley. “The benefits Perspire’s infrared sauna and red light therapy provides are unmatched. There’s a demand for the science-backed treatment and I’m excited to bring it to the Paradise Valley & Scottsdale community.”

Perspire Sauna Studio combines a centuries-old practice with modern-day science and technology to provide guests with a holistic, full-body health and wellness alternative that compliments and supports the active and healthy lifestyle, especially within Arizona. Benefits range from detoxification, weight loss, alleviating pain, enhanced immunity, clearer skin, improved sleep, relaxation, and more. A visit to Perspire feels like a relaxing retreat, where guests can unwind with personalized entertainment all while experiencing the healing benefits of the infrared sauna experience. Sessions are typically 40 minutes and walk-ins are always welcome.

As a nearly 30-year Phoenician, Rzeppa had a successful 20-year career working for a leading Valley high net worth investment advisor ultimately becoming a managing partner and chief administrative officer. In 2020, that company was acquired and Rzeppa began researching wellness franchise concepts to bring to her community.

“In addition to this studio, we’re planning to open two more studios in Arcadia and central Scottsdale within the next year. The benefits are too good to not share with as many people as possible,” adds Rzeppa.

Upon entering Perspire, guests are greeted with a consultation from a team member and are taken back to a private sauna room. Each sauna is outfitted with the ability to choose the temperature, entertainment, color light therapy, and high-intensity red light therapy ensuring a multi-sensory experience. In addition, cooling towels infused with eucalyptus are provided after each session for maximum cool down and comfort.

Perspire offers affordable sessions, encouraging guests to add an infrared sauna experience to their regular health and wellness routines. As of right now, the Paradise Valley studio is hosting founding membership specials including the “Relax Plan” for $49 per month, which includes four sessions per month (regularly priced at $69 a month) or the “Detox Plan” for $119 a month, which includes unlimited infrared sauna sessions (regularly priced at $159).

To learn more about Perspire Sauna Studio in Paradise Valley, please visit https://www.perspiresaunastudio.com/az/paradise-valley/ or at @perspire.paradisevalley on social media.

###

About Perspire Sauna Studio

Perspire Sauna Studio is the fastest-growing infrared sauna and red light therapy franchise in the U.S. The science-based, technology-driven, and wellness-seeking company provides guests a modern-day experience to a centuries-old practice, allowing their body and mind to feel refreshed after each session. Co-owned by Lee Braun and Ken Arsenian, Perspire’s goal is to expand to major markets throughout the U.S. to further instill its vision of making infrared wellness accessible to all.

Founded in 2010 and based in Southern California, Perspire Sauna Studio currently offers franchise opportunities to qualifying entrepreneurs. For more information, please visit http://www.perspiresaunastudio.com, and follow the brand on social media @perspiresaunastudio. For franchising information, please contact cory@perspiresaunastudios.com.

Share article on social media or email:

National Dolphin Day is a day to recognize and solve the endangerment of one of the ocean’s most beloved creatures.

SAN DIEGO (PRWEB)
April 05, 2022

Dolphins are among the planet’s most intelligent and social animals—but changes to their oceans are threatening their welfare. That’s why, in honor of National Dolphin Day on April 14, health and wellness company Seraphina Therapeutics is donating a percentage of its sales to support wild dolphin conservation efforts. Five percent of sales of the company’s fatty15 supplement from April 2-17 will go to the Sarasota Dolphin Research Program, which has supported conservation efforts for the past 50 years.

Seraphina has a deep connection to dolphin-kind. While studying how to continually improve the health and welfare of older dolphins, Seraphina’s co-founder and CEO Dr. Stephanie Venn-Watson, a veterinary epidemiologist, discovered a nutrient that not only helps protect the health of aging dolphins, but can help keep humans healthy, too.

That nutrient is C15:0 (pentadecanoic acid), one of several odd-chain saturated fats that Dr. Venn-Watson and her team found in the fish-based diets among the healthiest of dolphins, including those in Sarasota Bay, and published in PLOS ONE. After this initial discovery and years of subsequent studies, they found that pure C15:0 can help regulate glucose, immunity, and cholesterol. It also naturally activates receptors that orchestrate metabolism, immunity, mood, appetite, and sleep. These studies were published in “Nature’s Scientific Reports” during May 2020. Since that publication, dozens of peer-reviewed studies have linked higher circulating C15:0 concentrations to better metabolic, immune, heart and liver health in humans. Seraphina created a supplement, called fatty15, made of 99% pure, vegan-friendly, and bioavailable C15:0 powder. Fatty15 was launched during January 2021 and sold out within 6 weeks.

For its extensive studies on C15:0 and bringing a pure C15:0 ingredient (FA15) and supplement (fatty15) to the market, Seraphina was awarded the 2021 Best of the Industry Award by the editors of Nutritional Outlook Magazine.

Watch Dr. Venn-Watson’s TEDx San Diego talk (located at 3:08:08 into this stream) to learn how helping older dolphins live the longest, healthiest lives possible taught us how to age healthier, too – and how the C15:0 good fat present in their fish diets and our butter may improve health for all.

About: Seraphina Therapeutics, Inc. is a health and wellness company dedicated to advancing global health through the discovery of essential fatty acids and micronutrient therapeutics. Through rigorous breakthrough science, the company develops fatty acid supplements, food fortifiers, and nutritional interventions to strengthen cells, keep mitochondria working and advance cellular homeostasis to counter age-related breakdown. With its team of industry-leading scientists, Seraphina Therapeutics challenges long-held approaches to nutrition, enabling the creation of novel health products designed to support quality of life. The company is a spinout of Epitracker, Inc., headquartered in San Diego. For more information, please visit http://www.seraphinatherapeutics.com and http://www.fatty15.com.

Share article on social media or email:

SCOTTSDALE, Ariz. (PRWEB)
April 05, 2022

The NCPDP Foundation today announced Surescripts as its Role & Value of Pharmacist Founders Gift Donor. Surescripts’ donation of $100,000 will support future research projects over the next two years that demonstrate and measure one or more existing or future NCPDP standards that align with the Foundation’s strategic initiative to Expand the Role and Value of the Pharmacist. Surescripts’ Chief Marketing Officer, Melanie Marcus, will serve as the NCPDP Foundation’s National Advisory Council (NAC) Chair for Role and Value of the Pharmacist with support from senior pharmacists and pharmacy experts at Surescripts, NCPA and NACDS.

The NCPDP Foundation’s newly established NAC will focus its fundraising efforts in support of three research priorities: enhance patient safety; expand access to care; and expand the role and value of pharmacists. The NAC is composed of volunteer leaders who are committed to advancing NCPDP and its national initiatives. Members represent the highest levels of industry, philanthropy and non-governmental organizations and serve in an advisory rather than fiduciary role.

“Surescripts has supported previous NCPDP Foundation grants that prove the patient safety value of two NCPDP Standards by supporting the CancelRx projects completed by Johns Hopkins Medicine and University of Wisconsin-Madison School of Pharmacy. In addition, Surescripts supported the grant completed by Johns Hopkins that demonstrated the value of NCPDP’s Real-Time Benefit Standard. Enhancing the role and value of pharmacist is a natural fit for Surescripts to broaden its commitment to NCPDP and the NCPDP Foundation,” said J.W. Hill, MBAHCM, CNED, Executive Director, NCPDP Foundation.

Lee Ann Stember, NCPDP’s President & CEO and NCPDP Foundation Board Member, stated, “Through the use of one of our existing and widely adopted health IT standards, NCPDP made it possible for pharmacists to address the unique factors associated with electronically exchanging data required for ordering, administering, documenting, and filing claims for COVID-19 tests and vaccines. We are looking forward to additional research projects provided through this donation that can expand the role and value of pharmacist through our standards and we are very grateful for Surescripts partnership.”

“For more than 20 years, Surescripts has worked closely with NCPDP to drive standards-based health intelligence sharing,” explained Melanie Marcus, Chief Marketing Officer of Surescripts. “Today, as pharmacists are adapting to their evolving role in healthcare, we’re honored to continue to support their needs through the NCPDP Foundation, working to empower pharmacists with technology that removes friction and delays and gives them more time to focus on assisting and advising patients.”

About NCPDP Foundation

The NCPDP Foundation is a 501(c)(3) nonprofit charitable organization headquartered in Scottsdale, Arizona and is affiliated with the National Council for Prescription Drug Programs (NCPDP). The NCPDP Foundation was established in December 2012 to support research, education, and charitable involvement within the healthcare industry. For more information, visit http://ncpdpfoundation.org.

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and improve the quality of care. At Surescripts, we align healthcare organizations across the nation and give healthcare professionals the trusted insights they need to serve patients. We convene the Surescripts Network Alliance® to enhance prescribing, better inform care decisions and advance healthcare as a whole. Visit us at surescripts.com and follow us at twitter.com/surescripts.

###

Share article on social media or email:

“With 100,000 stories of transformation and 35 years of practice stacked with 3 Board Certified Plastic Surgeons, our mission is to educate patients while holding their hand on their journey to confidence.” – Dr. Niccole

CORONA DEL MAR, Calif. (PRWEB)
April 05, 2022

Voted by patients as one of the best plastic surgeons in Orange County, CosmetiCare founder and Medical Director Dr. Niccole has been the national and local media go-to for expert opinions on aesthetics, cutting edge technology and techniques, and education on the business of loving the way you look.

Proud to be one of the most trusted voices in plastic surgery and aesthetics, CosmetiCare’s award-winning team is excited to shed light on its most popular procedure, with a new educational series being released throughout the month on IGTV and YouTube. Dedicated to educating patients on all things breast augmentation, this highly anticipated series covers most frequently asked questions by patients, and those that CosmetiCare’s Board Certified Plastic Surgeons find crucial in the decision-making process:

• 
  Selecting the right implant size for your aesthetic goals
• Learning if you’d be a good candidate for a breast lift or breast reduction
• Understanding when and if it’s time for breast implant exchange
• Why selecting a Board-Certified plastic surgeon is more important than you may think

“We understand that having a surgical procedure brings up many questions for patients,” says Dr. Niccole. “With 100,000 stories of transformation and 35 years of practice stacked with 3 Board Certified Plastic Surgeons, our mission is to educate patients while holding their hand on their journey to confidence.”

If you’ve been considering a breast procedure, or are looking to exchange existing breast implants, this series is a must-watch. Follow us on Instagram or Facebook to see this Breast Procedure series with new topics released each week. If you’d like to “try on” any procedure to see how it could look on you, visit http://www.cosmeticare.com to use our complimentary simulation tool with easy photo upload from the comfort of your home and see your potential results.

###

ABOUT COSMETICARE

With a passion for providing the best patient care available, Dr. Michael Niccole founded CosmetiCare in 1982 and has built it into one of the leading plastic surgery and medspa centers recognized throughout the nation. CosmetiCare’s meticulously cultivated, award-winning team of doctors and medical professionals has provided more than 100,000 stories of transformation for over 35 years. The CosmetiCare team is devoted to guiding patients through the decision-making process with knowledgeable insight and proven results to ensure that clients look and feel their best. To learn more about CosmetiCare, visit http://www.cosmeticare.com

Press Contact:

Courtney Clements

cclements@cosmeticare.com

Share article on social media or email:

SpIntellx at AACR 2022, New Orleans

SpIntellx has the first-mover advantage in precision pathology by applying truly unbiased spatial analytics to decipher the complex cancer biology.

PITTSBURGH (PRWEB)
April 05, 2022

SpIntellx, Inc. created the new era of precision pathology to dramatically improve patient outcomes by leveraging proprietary unbiased spatial analytics and explainable AI. SpIntellx’s precision pathology solutions have the potential to unlock a plethora of new applications in medicine and research by answering the fundamental question “Why?” , thus revealing the underlying patient-specific disease network biology across each stage of the drug development, diagnostics, and treatment pipelines.

SpIntellx offers software as a service (SaaS) for precision pathology applications harnessing unbiased spatial analytics and explainable AI including: accelerated drug discovery for identifying novel targets, biomarkers and “invisible” cell types; optimized clinical trials for precision patient stratification; advanced companion diagnostics for radically improving prediction accuracies through deep insights into biological mechanisms of action; and personalized therapeutic options for selecting optimal therapeutics based on insights into probable patient outcomes.

Chakra Chennubhotla, PhD, CEO of SpIntellx, stated “Our analytical software platform performs truly unbiased and fully automated functional cell phenotyping derived from spatial network analysis of biomarker relationships using the full intensity scale of the complete panel of biomarkers across entire tissue sample with no need for ground truth or tagged data. We are also agnostic to imaging platforms and our SaaS service delivers unmatched knowledge from image data to our customers.”

At AACR 2022, SpIntellx will demonstrate results in (i) hyperplexed immunofluorescence dataset on colorectal cancer and hyperplexed imaging mass cytometry dataset on triple negative breast cancer with TumorMapr for discovering functional cell types (e.g., transitional cells) highly predictive of disease progression and response to therapy, and for identifying microdomain-specific network biology driving recurrence, and (ii) transmitted light datasets of breast biopsies with HistoMapr for differentiating and ranking a broad spectrum of diagnostic categories including low-risk benign, high-risk benign including atypia, ductal carcinoma in situ and invasive carcinoma.

D. Lansing Taylor, PhD, Executive Chairman of SpIntellx, stated “SpIntellx has the first-mover advantage in precision pathology by applying truly unbiased spatial analytics to decipher the complex cancer biology. Our approach leads to the discovery of a continuum of unbiased cell phenotypes capturing functional plasticity associated with cancer progression and therapeutic response, thus making better outcomes for patients. We have built a robust pipeline of early customers including pharma partners who are combining TumorMapr and HistoMapr to discover why some patients responded to therapy and some did not in their clinical trials. Our customers recognize the value of our solutions that can scale all the way from early discovery to clinical research.”

About SpIntellx:

SpIntellx, Inc., is the precision pathology company based in Pittsburgh, PA that applies its proprietary unbiased spatial analytics and explainable AI to transform computational and systems pathology to precision pathology and guide clinicians and researchers with powerful tools so they can See More, Know More, and Power Precision Pathology. Early investors include Newlin Investment Company LLC (http://www.newlininvestment.com) and Innovation Works (http://www.innovationworks.org). SpIntellx is completing a convertible note that will convert into the Series A that is planned for later this year. For more information on SpIntellx, please visit: http://www.spintellx.com

Contact: info@spintellx.com

SpIntellx, Inc.

100 S. Jackson Ave.

Pittsburgh, PA 15202

https://www.spintellx.com

https://www.linkedin.com/company/spintellx/

https://twitter.com/spintellx

Share article on social media or email:

MURFREESBORO, Tenn. (PRWEB)
April 05, 2022

TwelveStone Health Partners, a leading provider of comprehensive chronic care medication services, announces the opening of a new infusion center serving the city of Spring Hill, Tennessee, and community south of Davidson County.

“We are so pleased to offer patients in Spring Hill and surrounding communities the option to have an infusion done in a comfortable and convenient location for complex medication regimes that can’t be administered at home,” says Shane Reeves, chief executive officer at TwelveStone. “Nashville has grown significantly in the past few years and getting into the city can be a challenge for those living with a chronic medical condition.”

The outpatient infusion suites allow TwelveStone to administer a broader array of medications with medical oversight. Also, the first infusion therapy dose of any medication is required to be managed in an outpatient setting so the procedure can be closely monitored by medical professionals.

Brook Daniels, a nurse practitioner, is the team lead at the center which joins a growing network that also includes locations in Chattanooga, Knoxville, Mt. Juliet and the company’s headquarters in Murfreesboro, Tennessee, as well as Canton Georgia and Roanoke Virginia.

The new location is located at the 840 and Columbia Pike exit, at 150 Stephen P Yokich Parkway, Suite H, Spring Hill, TN 37174. A ribbon cutting has been planned for Thursday, April 7th from 11:30 to 1:00 PM including local members of the Chamber of Commerce. The public is invited to tour the facility at that time.

TwelveStone Infusion Centers are designed to offer private suits in a peaceful and comforting environment while still providing all the benefits of a medically supervised, safe clinical environment. Entertainment such as TV and free wi-fi services are available. Infusion therapy appointments are available Monday through Friday from 7:00 a.m. to 5:00 p.m.

“We have already received positive feedback from patients at the Spring Hill location,” shared Daniels. “We are pleased to serve the greater Spring Hill community and the local referring specialists.”

For more information visit: https://www.12stonehealth.com/infusion-center/spring-hill-tn

ABOUT TWELVESTONE HEALTH PARTNERS

TwelveStone Health Partners incorporates the objective of glorifying God into its mission by delivering a higher level of service to partners and patients. As an organization, TwelveStone supports the transition from acute to post-acute care environments and the transition from sickness to health. This is the third evolution in the company’s history, beginning in 1980 when Richard Reeves and Ronald Powell created a single retail pharmacy location then called Reeves Powell Saveway Drug Store. In 1994 Shane Reeves and Rick Sain launched Reeves-Sain and over 20 years grew the organization to include seven companies. In 2015 Reeves Sain Drug Store, Inc., a retail pharmacy, and its specialty pharmacy, EntrustRx were sold to Fred’s, Inc. In 2016 Shane Reeves launched TwelveStone Health Partners with the objective of continuing to pursue the highest professional, business and community goals set forth by its founders. For more information visit http://www.12stonehealth.com.

Share article on social media or email:

SPECIFIC REVEAL® Rapid AST System

“We anticipate and look forward to a productive exchange of information with leading investors as we bring Reveal to the market in Europe alongside our distribution partner bioMérieux, and as we complete our 510k studies for entry to the US market,” said Dr. Rhodes.

SAN JOSE, Calif. (PRWEB)
April 05, 2022

Specific Diagnostics has been invited to participate in the PrivaTRAK at William Blair’s 42nd Annual Growth Stock Conference, to be held June 7-8th of this year in Chicago, Illinois.

The conference is a highly differentiated, premier investor conference where exclusively selected private companies meet with institutional investors in a one-on-one forum. “Whereas many institutional investor conferences tend to attract sector analysts from buyside investors, our conference has always attracted a high percentage of portfolio managers from long-term, blue chip investors, including a healthy percentage of investors from Europe,” remarks Rakhee Bhagat, a managing director for William Blair.

“We are looking forward to continuing discussion with the diagnostics investor community and sharing our story with the William Blair & Company Annual Growth Stock Conference this year,” said Dr. Paul A. Rhodes, Specific’s CEO.

This conference will be Specific’s third presentation to the investor community in the last 12 months.

“We anticipate and look forward to a productive exchange of information with leading investors as we bring Reveal to the market in Europe alongside our distribution partner bioMérieux, and as we complete our 510k studies for entry to the US market,” said Dr. Rhodes.

About Specific

Specific Diagnostics has developed in vitro diagnostic systems based upon a unique, patented metabolomic signature technology that enables rapid detection and identification of microorganisms as they grow in culture. Its first commercial application applies this fundamental new platform to the rapid determination of antimicrobial susceptibility directly from positive blood cultures, as well as isolate dilutions. The SPECIFIC REVEAL® Rapid AST System is not yet cleared by the FDA for use in diagnostic procedures in the United States. The SPECIFIC REVEAL™ is CE Marked and available for use in Europe and in other jurisdictions outside the United States for which regulatory clearance is based upon the CE Mark. Specific is based in San Jose, CA, with subsidiaries in Ireland, France and the UK.

For press inquiries, please contact: press@specificdx.com

https://specificdx.com/

Share article on social media or email: